Brenntag SE (ETR:BNR)
Germany · Delayed Price · Currency is EUR 61.56
+2.30 (3.88%)
Jul 28, 2026, 4:14 PM CET
Brenntag SE Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 14,762 | 15,172 | 16,237 | 16,815 | 19,429 | 14,383 |
Revenue Growth | -9.48% | -6.56% | -3.44% | -13.46% | 35.09% | 21.94% |
Gross Profit Gross Profit Growth | 3,762 | 3,832 | 4,027 | 4,020 | 4,319 | 3,379 |
Operating Income Operating Income Growth | 562.5 | 617.6 | 915.4 | 1,123 | 1,382 | 742.4 |
Net Income Net Income Growth | 228.2 | 264.6 | 536.2 | 714.9 | 886.8 | 448.3 |
Earnings Per Share EPS Growth | 1.58 | 1.83 | 3.71 | 4.73 | 5.74 | 2.89 |
EPS Growth | -56.95% | -50.67% | -21.56% | -17.60% | 98.62% | -4.30% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Brenntag Specialties - Life Science Brenntag Specialties - Life Science Growth | 3,100 | 3,193 | 3,483 | 3,710 | - | - |
Brenntag Specialties - Specialties Other Brenntag Specialties - Specialties Other Growth | 45.7 | 46.7 | 58.9 | 77.7 | - | - |
Brenntag Essentials - Europe, Middle East & Africa (EMEA) Brenntag Essentials - Europe, Middle East & Africa (EMEA) Growth | 3,573 | 3,608 | 3,741 | 3,865 | 4,293 | 3,187 |
Brenntag Essentials - Transregional Brenntag Essentials - Transregional Growth | 255.4 | 276.4 | 335 | 522.9 | - | - |
Brenntag Essentials - North America Brenntag Essentials - North America Growth | 4,540 | 4,694 | 5,163 | 5,271 | 4,780 | 3,269 |
Brenntag Essentials - Latin America Brenntag Essentials - Latin America Growth | 950.4 | 968.4 | 763.4 | 758.8 | 861.4 | 634.5 |
Brenntag Essentials - Asia Pacific (APAC) Brenntag Essentials - Asia Pacific (APAC) Growth | 748.8 | 823.8 | 1,006 | 943.9 | 787.2 | 725.7 |
Brenntag Specialties - Material Science Brenntag Specialties - Material Science Growth | 1,549 | 1,562 | 1,688 | 1,666 | - | - |
Total Total Growth | 14,762 | 15,172 | 16,237 | 16,815 | 19,429 | 14,383 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 696 | 797.9 | 763.3 | 576.9 | 1,046 | 705 |
Total Debt Total Debt Growth | 3,381 | 3,326 | 3,556 | 2,764 | 3,096 | 2,775 |
Net Cash (Debt) Net Cash Growth | -2,685 | -2,528 | -2,793 | -2,187 | -2,050 | -2,070 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -18.59 | -17.51 | -19.30 | -14.47 | -13.27 | -13.37 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 947.4 | 966.7 | 906.6 | 1,664 | 956.7 | 388.6 |
Capital Expenditures CapEx Growth | -291.7 | -293 | -342.2 | -321.1 | -267.2 | -199.3 |
Free Cash Flow Free Cash Flow Growth | 655.7 | 673.7 | 564.4 | 1,343 | 689.5 | 189.3 |
Free Cash Flow Growth | 15.16% | 19.37% | -57.97% | 94.75% | 264.24% | -81.44% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 25.49% | 25.26% | 24.80% | 23.91% | 22.23% | 23.49% |
Operating Margin | 3.81% | 4.07% | 5.64% | 6.68% | 7.12% | 5.16% |
Pretax Margin | 2.98% | 3.20% | 4.57% | 5.96% | 6.36% | 4.52% |
Profit Margin | 1.58% | 1.78% | 3.35% | 4.29% | 4.65% | 3.21% |
FCF Margin | 4.44% | 4.44% | 3.48% | 7.99% | 3.55% | 1.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.900 | 1.900 | 2.100 | 2.100 | 2.000 | 1.450 |
Dividend Per Share Growth | -9.52% | -9.52% | 0% | 5.00% | 37.93% | 7.41% |
Dividend Yield | 3.21% | 4.24% | 3.62% | 2.42% | 2.43% | 1.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.59 | 27.08 | 15.60 | 17.59 | 10.40 | 27.54 |
Forward PE | 13.01 | 12.93 | 11.88 | 14.71 | 8.97 | 16.90 |
P/FCF Ratio | 13.03 | 10.62 | 14.81 | 9.14 | 13.38 | 64.95 |
PS Ratio | 0.58 | 0.47 | 0.51 | 0.73 | 0.47 | 0.85 |